Voss Capital’s Lantern Pharma LTRN Stock Holding History

Voss Capital’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$68.5K	Hold	50,000	–	–	﹤0.01%	53
2025 Q4	$152K	Hold	50,000	–	–	0.01%	57
2025 Q3	$218K	Hold	50,000	–	–	0.01%	57
2025 Q2	$158K	Hold	50,000	–	–	0.01%	53
2025 Q1	$177K	Hold	50,000	–	–	0.01%	55
2024 Q4	$160K	Buy	+50,000	New	+$171K	0.01%	45
2021 Q1	–	Sell	-25,906	Closed	-$499K	–	50
2020 Q4	$499K	Sell	25,906 -9,161	-26%	-$158K	0.25%	40
2020 Q3	$661K	Buy	+35,067	New	+$508K	0.38%	42

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Voss Capital's LTRN Position: Q1 2026 in Review

Voss Capital held its Lantern Pharma (LTRN) position steady in Q1 2026 at 50,000 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #53.

Voss Capital first reported a position in LTRN in Q3 2020 and has held it in 8 quarters since. The position peaked at $661K in Q3 2020. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

Voss Capital held 50,000 shares of Lantern Pharma worth $68.5K as of Q1 2026.
Voss Capital left its Lantern Pharma share count unchanged in Q1 2026.
Lantern Pharma made up ﹤0.01% of Voss Capital's portfolio in Q1 2026, its #53 holding.
Voss Capital first reported a position in Lantern Pharma in Q3 2020 and has held it in 8 quarters since.
Voss Capital's Lantern Pharma position peaked at $661K in Q3 2020.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Voss Capital's 13F filing for Q1 2026, filed 15 May 2026.